Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00643071
Recruitment Status : Completed
First Posted : March 26, 2008
Last Update Posted : August 26, 2014
Information provided by (Responsible Party):
Astellas Pharma Inc

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2008
Actual Study Completion Date : May 2008